CoChat

Insulin resistance and sarcopenia: mechanistic links between common co-morbidities

Open access
Cleasby, Mark E, Jamieson, Pauline M, Atherton, Philip J · 2016 · Journal of Endocrinology

The DOI matches its Crossref record; 160 of the 163 references it cites were found in a registry or an index.

Abstract

Insulin resistance (IR) in skeletal muscle is a key defect mediating the link between obesity and type 2 diabetes, a disease that typically affects people in later life. Sarcopenia (age-related loss of muscle mass and quality) is a risk factor for a number of frailty-related conditions that occur in the elderly. In addition, a syndrome of ‘sarcopenic obesity’ (SO) is now increasingly recognised, which is common in older people and is applied to individuals that simultaneously show obesity, IR and sarcopenia. Such individuals are at an increased risk of adverse health events compared with those who are obese or sarcopenic alone. However, there are no licenced treatments for sarcopenia or SO, the syndrome is poorly defined clinically and the mechanisms that might explain a common aetiology are not yet well characterised. In this review, we detail the nature and extent of the clinical syndrome, highlight some of the key physiological processes that are dysregulated and discuss some candidate molecular pathways that could be implicated in both metabolic and anabolic defects in skeletal muscle, with an eye towards future therapeutic options. In particular, the potential roles of Akt/mammalian target of rapamycin signalling, AMP-activated protein kinase, myostatin, urocortins and vitamin D are discussed.

Overview

Integrity signals

Registry

Crossref · 10.1530/joe-15-0533

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Research works printed but not linked: 1

  1. 10.2337/diacare.294895 · doi:10.2337/diacare.294895

Cited by

See all 654

Metadata

Authors
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J.
Affiliations
  • University of London (GB)
  • The Queen's Medical Research Institute (GB)
  • University of Nottingham (GB)
Corresponding author
Cleasby, Mark E
Venue
Journal of Endocrinology
Published
2016-05
Volume
229
Issue
2
Pages
R67-R81
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
OpenAlex
W2288712562
Cited by
596
References
163
Citations by year
2026: 58 · 2025: 79 · 2024: 77 · 2023: 71 · 2022: 73 · 2021: 69 · 2020: 55 · 2019: 40 · 2018: 40 · 2017: 25 · 2016: 9
FWCI
4.45
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
  • RVC Research Online (Royal Veterinary College) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (087461)
  • Diabetes UK (13/0004683, BDA 13/0004683)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Keywords
insulin resistance, sarcopenia, sarcopenic obesity, skeletal muscle, type 2 diabetes, obesity, frailty, older adults, Akt/mTOR signaling, AMPK, myostatin, urocortin, vitamin D, muscle anabolism, muscle metabolism, therapeutic target
MeSH terms
Aged, Diabetes Mellitus, Type 2, Female, Glucose, Humans, Insulin Resistance, Male, Models, Biological, Muscle Proteins, Obesity, Signal Transduction, Comorbidity, Adipocytes, Lipid Metabolism, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.